`

XenoPort, Inc

Pharmaceutical Manufacturing

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$20.0M
size-icon Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About XenoPort, Inc

What does Xenoport, inc do?+

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPorts pipeline of product candidates includes potential treatments for patients with Parkinsons disease, relapsing-remitting multiple sclerosis and psoriasis

What is Xenoport, inc's industry? +

Xenoport, inc operates in the Pharmaceutical manufacturing industry.

What is Xenoport, inc's revenue? +

Xenoport, inc's revenue is 11m - 100m

What is Xenoport, inc's company size? +

Xenoport, inc has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free